Schedule 13D ownership disclosure

Celator Pharmaceuticals Inc

Security class unavailable · CUSIP: 15089R102

Event date: 2016-04-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,438,223
Percent of class
3.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-16-012601
Form type
SC 13D/A
Filer
CAXTON CORP
CIK
CIK 1388551
Filed
Apr 22, 2016
Reporting period
Apr 21, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub